Loading wiki pages...

Wiki Version:
<p>Author: Joshua Cohen</p> <p>Background: We developed a model to evaluate treatments for early-stage Hodgkin Lymphoma (HL). The purpose of the model is to project long-term impacts of alternative treatments for HL, taking into account late effects associated with HL treatment.</p> <p>Methods: INTERVENTIONS: (1) Chemotherapy alone, and (2) Chemotherapy plus radiation therapy. POPULATION: two prototypical patients: "Patient 1: a 25-year-old male with favorable ESHL (stage IA); Patient 2: a 25-year-old female with unfavorable ESHL (stage IIB)" (from abstract). OUTCOMES: QALYs and LYs.</p> <p>Results: For Patient 1, CMT was superior to CA (CMT incremental gain = 0.11 QALYs, 0.21 LYs). For Patient 2, CA was superior to CMT (CA incremental gain = 0.37 QALYs, 0.92 LYs).</p> <p>Conclusion: Therapy benefits depend on patient characteristics.</p>
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.